应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02186 绿叶制药
休市中 06-12 16:08:21
1.890
+0.020
+1.07%
最高
1.920
最低
1.850
成交量
3,887万
今开
1.890
昨收
1.870
日振幅
3.74%
总市值
75.51亿
流通市值
75.51亿
总股本
39.95亿
成交额
7,360万
换手率
0.97%
流通股本
39.95亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
绿叶制药(02186)完成发行1.8亿美元5.25%利率2031年到期可转换债券
智通财经 · 06-11 08:02
绿叶制药(02186)完成发行1.8亿美元5.25%利率2031年到期可转换债券
港股午评|恒生指数早盘跌1.4% 半导体逆市走高
智通财经 · 06-04
港股午评|恒生指数早盘跌1.4% 半导体逆市走高
1.8亿美元可转债“以新换旧”,绿叶制药净筹约1.77亿美元
财中社 · 06-04
1.8亿美元可转债“以新换旧”,绿叶制药净筹约1.77亿美元
智通港股早知道 | 富时中国50指数调整纳入兆易创新(03986) 小马智行(02026)、文远知行(00800)纳入港股通
智通财经 · 06-04
智通港股早知道 | 富时中国50指数调整纳入兆易创新(03986) 小马智行(02026)、文远知行(00800)纳入港股通
绿叶制药(02186)拟同步回购1.8亿美元2028年到期可转换债券及发行美元计价可转换债券
智通财经 · 06-03
绿叶制药(02186)拟同步回购1.8亿美元2028年到期可转换债券及发行美元计价可转换债券
绿叶制药2026年5月股份变动月报表:股本维持不变
公告速递 · 06-03
绿叶制药2026年5月股份变动月报表:股本维持不变
绿叶制药授予董事股份购回授权,规模达已发行股本一成
公告速递 · 05-29
绿叶制药授予董事股份购回授权,规模达已发行股本一成
绿叶制药4月股份变动月报表:股本规模保持稳定
公告速递 · 05-07
绿叶制药4月股份变动月报表:股本规模保持稳定
绿叶制药2025年度收入达63.08亿元,归母净利同比增31.1%
公告速递 · 04-29
绿叶制药2025年度收入达63.08亿元,归母净利同比增31.1%
绿叶制药(02186)创新药LY03015(VMAT2抑制剂╱Sigma-1R激动剂)美国PK桥接临床试验完成首例受试者入组
智通财经 · 04-20
绿叶制药(02186)创新药LY03015(VMAT2抑制剂╱Sigma-1R激动剂)美国PK桥接临床试验完成首例受试者入组
港股公告掘金 | 宁德时代一季度归母净利润207.38亿元 同比增长48.52%
智通财经 · 04-16
港股公告掘金 | 宁德时代一季度归母净利润207.38亿元 同比增长48.52%
绿叶制药(02186)创新药LY03017用于治疗阿尔茨海默病精神病性障碍的中国Ⅱ期临床试验完成首例受试者入组
智通财经 · 04-15
绿叶制药(02186)创新药LY03017用于治疗阿尔茨海默病精神病性障碍的中国Ⅱ期临床试验完成首例受试者入组
【券商聚焦】东北证券首予绿叶制药(02186)“增持”评级 指新产品加速放量
金吾财讯 · 04-15
【券商聚焦】东北证券首予绿叶制药(02186)“增持”评级 指新产品加速放量
大行评级丨花旗:下调绿叶制药目标价至4.3港元,重申“买入”评级
中金财经 · 04-14
大行评级丨花旗:下调绿叶制药目标价至4.3港元,重申“买入”评级
港股异动 | 绿叶制药(02186)午前涨近3% 近日自研创新药LY03020中国Ⅱ期临床试验完成首例受试者入组
智通财经 · 04-14
港股异动 | 绿叶制药(02186)午前涨近3% 近日自研创新药LY03020中国Ⅱ期临床试验完成首例受试者入组
瑞银增持绿叶制药(02186)1395.45万股 每股作价约2.85港元
智通财经 · 04-13
瑞银增持绿叶制药(02186)1395.45万股 每股作价约2.85港元
绿叶制药(02186):创新药LY03020中国Ⅱ期临床试验完成首例受试者入组
智通财经 · 04-08
绿叶制药(02186):创新药LY03020中国Ⅱ期临床试验完成首例受试者入组
绿叶制药2026年3月股份变动月报表,股本维持不变
公告速递 · 04-08
绿叶制药2026年3月股份变动月报表,股本维持不变
BD+业绩双重炸裂,创新药多股涨停,黄金窗口期来了?
格隆汇 · 04-02
BD+业绩双重炸裂,创新药多股涨停,黄金窗口期来了?
异动解读 | 绿叶制药盘中大涨5.17%,2025年股东应占溢利同比增长31.12%
异动解读 · 04-02
异动解读 | 绿叶制药盘中大涨5.17%,2025年股东应占溢利同比增长31.12%
暂无数据
公司概况
公司名称:
绿叶制药
所属市场:
SEHK
上市日期:
--
主营业务:
绿叶制药集团有限公司是一家主要从事药品的开发、生产、推广及销售的公司。该公司经营四个分部,包括肿瘤药物分部、心血管系统药物分部、消化与代谢药物分部和中枢神经系统药物分部。肿瘤药物分部提供力扑素、博优诺、百拓维、希美纳及米美欣等药品。心血管系统药物分部提供血脂康、欧开及麦通纳等药品。消化与代谢药物分部提供贝希等药品。中枢神经系统药物分部提供思瑞康、若欣林、瑞可妥、美比瑞及金悠平等药品。
发行价格:
--
{"stockData":{"symbol":"02186","market":"HK","secType":"STK","nameCN":"绿叶制药","latestPrice":1.89,"timestamp":1781251701004,"preClose":1.87,"halted":0,"volume":38867309,"delay":0,"changeRate":0.010695187165775291,"floatShares":3995000000,"shares":3995000000,"eps":0.158823,"marketStatus":"休市中","change":0.02,"latestTime":"06-12 16:08:21","open":1.89,"high":1.92,"low":1.85,"amount":73601082,"amplitude":0.037433,"askPrice":1.89,"askSize":4282500,"bidPrice":1.88,"bidSize":1307000,"shortable":3,"etf":0,"ttmEps":0.17674,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781487000000},"marketStatusCode":7,"adr":0,"listingDate":1404835200000,"exchange":"SEHK","adjPreClose":1.87,"openAndCloseTimeList":[[1781227800000,1781236800000],[1781240400000,1781251200000]],"volumeRatio":0.7863284126042215,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02186/tweets","defaultTab":"tweets","newsList":[{"id":"2642474015","title":"绿叶制药(02186)完成发行1.8亿美元5.25%利率2031年到期可转换债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2642474015","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642474015?lang=zh_cn&edition=full","pubTime":"2026-06-11 08:02","pubTimestamp":1781136158,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿叶制药(02186)发布公告,认购协议所载发行债券的所有先决条件均已获达成,且认购及发行本金总额为1.8亿美元的债券已于2026年6月10日完成。该等债券已于2026年6月10日在维也纳证券交易所上市。每股转换股份的初步换股价为2.71港元,较:股份于2026年6月3日(即签署认购协议的交易当日)在联交所所报收市价2.170港元溢价约24.9%;及股份于直至2026年6月2日(包括该日)止最后五个连续交易日在联交所所报收市价的平均价每股2.184港元溢价约24.1%。转换股份上市及买卖批准已获联交所授予。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452911.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","ZBmain","ZTmain","BK1583","BK1606","BNDW","TNmain","ZNmain","UBmain","ZFmain","02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640139070","title":"港股午评|恒生指数早盘跌1.4% 半导体逆市走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2640139070","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640139070?lang=zh_cn&edition=full","pubTime":"2026-06-04 12:00","pubTimestamp":1780545643,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,港股恒生指数跌1.4%,跌358点,报25274点;恒生科技指数跌1.43%。港股早盘成交1438亿港元。兆易创新逆市涨超9%,首季度全球NAND市场规模环比接近翻倍,机构指利基存储将全面涨价。中兴通讯 涨4.3%,与腾讯达成深度战略合作,双方即将重磅发布WorkBuddy AI云电脑。有色股集体承压。能源涨价推高通胀水平,美联储加息预期走高。洛阳钼业跌5.7%;五矿资源跌4.4%。黄金股跌幅居前,高油价推高通胀预期,多家大行同时下调金价预测。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449988.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1115378108.SGD","LU0821914370.USD","HK0000352382.USD","LU0608807946.USD","LU2251237488.HKD","LU2293587155.HKD","HK0000914686.HKD","LU1868838027.USD","LU0449515922.USD","LU1810669033.SGD","LU0531970944.HKD","LU1770036033.HKD","IE00BZ08YS42.EUR","IE00B031HY20.USD","LU0048388663.USD","LU2051468812.USD","LU1366334578.USD","LU0449509016.USD","LU1720050803.USD","LU1642822792.SGD","SG9999014674.SGD","LU1814569148.SGD","LU2449936058.SGD","LU2008162690.USD","SG9999002562.SGD","SG9999018857.SGD","02631","LU1282651121.HKD","LU0823039010.USD","LU0823041008.USD","LU1960683339.HKD","LU1813983027.USD","LU0823038988.USD","LU2476274720.SGD","688347","LU0572939691.SGD","LU2362541273.HKD","LU0072913022.USD","HK0000151867.HKD","LU0608807433.USD","BK1149","SG9999000418.SGD","SG9999001051.SGD","LU0210527791.USD","LU1439102457.SGD","LU0244354667.USD","LU0106252389.USD","LU0862451753.SGD","LU0072462343.USD","LU0345775950.USD","IE00B3M56506.USD","LU0431992006.USD","HSTECH","LU0289960550.SGD","LU0488056044.USD","IE00B067MR52.USD","BK1095","LU0700851271.USD","SG9999001226.SGD","LU0607220059.USD","LU0588546209.SGD","BK1516","LU2097828474.EUR","LU0188438112.USD","LU0348783662.USD","LU0683595622.HKD","LU1023057109.AUD","SGXZ31699556.SGD","LU0871576103.HKD","LU0264606111.USD","LU0878004406.USD","LU0049112450.USD","LU0738912210.USD","LU2498475776.HKD","LU0791591158.USD","LU1282651048.USD","IE0034224299.USD","LU2317271919.USD","LU0229945570.USD","IE00BZ08YR35.GBP","BK1526","LU0675040207.SGD","GB00BDT5M118.USD","BK1583","LU0326948709.USD","LU0856984785.SGD","LU0143863198.USD","LU0327786744.USD","LU1481107354.HKD","LU0456854461.SGD","SG9999001069.SGD","HSI","LU1831875114.USD","LU0898667661.SGD","LU0414403682.SGD","IE00B0169L03.USD","LU0886674414.USD","IE0003795394.USD","LU0878005551.USD","LU2125910849.SGD","IE0008368411.USD","SG9999002463.SGD","LU1328277881.USD","LU0266512473.USD","LU1064130708.USD","LU1504937902.USD","LU0128522157.USD","01347","SG9999006597.SGD","LU1008478684.HKD","LU0345780521.USD","LU1211504680.USD","LU1282649067.USD","LU2087589342.USD","BK1586","LU1226288253.USD","LU1807302812.USD","LU2237443549.SGD","LU0455707207.USD","LU1196710195.USD","09115","LU0315178854.USD","HK0001040143.USD","IE00B5MMRT66.SGD","LU2125910500.SGD","LU0359202008.SGD","BK1594","LU0269904917.USD","LU2279701549.SGD","LU0140636845.USD","IE0031814852.USD","LU0828237510.HKD","LU0320764243.SGD","SG9999015978.USD","LU0117841782.USD","HK0000306685.HKD","IE00BF5LJ272.USD","LU1224709979.USD","LU0329678337.USD","LU0823413660.USD","LU0348788117.USD","03115","SG9999018865.SGD","LU1152091168.USD","LU1303224171.USD","LU0543330483.HKD","LU1974910355.USD","BK1198","TCEHY","SG9999000459.SGD","LU0985320562.USD","SG9999001093.SGD","SG9999007991.SGD","MCHmain","513600","LU0348827113.USD","LU0348825331.USD","LU3063872942.SGD","LU1051769294.HKD","LU1629966141.USD","LU0348816934.USD","LU1224444064.USD","LU0516422440.USD","LU0577902298.EUR","LU2106854487.HKD","07300","LU0181495838.USD","LU1917777945.USD","LU0882747503.HKD","LU2929501877.USD","LU1242518857.USD","LU0293314216.USD","SG9999014914.USD","IE00BZ08YT58.USD","LU0029875118.USD","LU0164880469.USD","LU1981816686.USD","LU0540923850.HKD","LU0328353924.USD","IE00BQXX3D17.EUR","LU1235295612.USD","BK1544","BK1592","LU1226287529.USD","LU0589944569.HKD","LU0516422366.SGD","LU0345776255.USD","LU1883866441.USD","LU1282648689.USD","LU0049853897.USD","BK1170","SG9999006514.SGD","LU0345780281.USD","IE00BQXX3F31.USD","LU1868837565.USD","LU0192582467.USD","LU0211331839.USD","BK1607","SG9999013353.USD","LU1226287875.USD","LU2023250504.SGD","LU0588545904.SGD","LU0791590937.USD","03419","LU0359201612.USD","LU1785774172.SGD","LU0456827905.SGD","LU0823413587.USD","LU0143863784.USD","LU0972618739.USD","LU0502904849.HKD","LU1804176565.USD","IE00BGV7N243.SGD","LU1808992512.USD","LU0605514214.HKD","LU1880383366.USD","02186","LU0463099449.HKD","LU0543330566.HKD","IE00B0JY6N72.USD","LU0501845795.SGD","LU2242644610.SGD","BK1506","LU1251922891.USD","LU0203347892.USD","LU0287142896.SGD","LU0345769128.USD","LU1102505929.USD","LU0082770016.USD","LU1366334651.USD","LU0080751232.USD","IE00BPRC5H50.USD","LU1691799644.USD","IE0003851619.USD","LU0348735423.USD","LU0634319403.HKD","LU2778985437.USD","LU0345769631.USD","IE00B97KM107.HKD","LU0149721374.USD","LU0873338254.USD","LU1688375341.USD","LU1961090484.USD","SG9999001689.USD","LU0043850808.USD","LU0359201885.HKD","02577","IE00B8HQ1Z84.USD","BK1615","LU0541502299.USD","SG9999014906.USD","601899","SG9999015986.USD","LU0173614495.USD","LU0061477393.USD","IE0008368742.USD","LU0572940350.SGD","SG9999000327.SGD","LU0054450605.USD","LU0169518387.USD","BK1610","LU1515016050.SGD","LU2148510915.USD","LU2264538146.SGD","00894","LU1044876610.USD","LU0261950983.USD","LU1152091754.HKD","LU1196710351.USD","LU0052750758.USD","LU0228659784.USD","LU1064131342.USD","LU2362541513.USD","LU2226246903.HKD","LU0531971595.HKD","LU0823397285.USD","SG9999015952.SGD","LU2045819591.USD","LU0541501648.USD","LU0165289439.USD","BK1169","LU1733274390.USD","LU2133065610.SGD","LU0164865239.USD","LU0918141887.USD","LU1655091459.SGD","LU2097828631.EUR","LU0611395673.USD","LU0235996351.USD","LU2213484517.USD","IE00B8L5B284.USD","LU1044875133.USD","LU1048596156.SGD","LU2251237306.USD","LU0231483743.USD","LU0918141705.HKD","LU0039217434.USD","LU2265009873.SGD","SG9999001903.USD","IE00B031HW06.USD","LU2237443382.USD","LU1568876335.HKD","LU2187417386.USD","LU0823040885.USD","BK1529","LU2097828557.USD","BK1521","LU0117844026.USD","LU0320764599.SGD","HK0000352291.HKD","LU1105468828.SGD","LU1226288170.HKD","LU1048484197.HKD","000063","LU1051768304.USD","LU0196878994.USD","LU0348814723.USD","IE00B0169N27.USD","LU0348784397.USD","LU0708995153.HKD","JINFF","LU0651947912.USD","LU2152927971.USD","LU1719994722.HKD","LU0128522744.USD","LU0106259558.USD","603993","BK1618","LU2177674079.SGD","LU1439103000.SGD","LU2362540622.SGD","LU0106959298.USD","LU0251144936.SGD","LU0593848301.USD","SG9999014880.SGD","82800","LU0048580855.USD","LU2237443622.USD","SG9999001846.SGD","02899","BK1511","LU0633140560.USD","LU0561508036.HKD","03986","LU0211977185.USD","LU0051755006.USD","LU1993786604.SGD","LU1316542783.SGD","LU0862451837.USD","07500","LU0708995583.HKD","BK1190","LU0210533765.USD","LU0011963245.USD","LU0819123356.HKD","BK1502","LU0786609619.USD","603986","LU0314109678.HKD","LU0828238088.HKD","LU2237443895.HKD","BK1608","03037","BK1505","HK0000914660.USD","BK1522","LU0651946864.USD","LU1868837722.USD","LU0084288322.USD","BK1517","LU0259732245.USD","LU0266512127.USD","IE0008369823.USD","LU0594300179.USD","LU1568876251.USD","IE00BQXX3C00.GBP","00763","LU0307460666.USD","LU0456842615.SGD","LU0516422952.EUR","IE0003895053.USD","LU2237443465.HKD","SGXZ51526630.SGD","LU2247934214.USD","BK1609","LU0348723411.USD","LU0127658192.USD","LU0979878070.USD","LU0210526637.USD","02833","LU0132412106.USD","LU0417516571.SGD","LU2462611646.USD","LU0880133367.SGD","LU0642271901.SGD","LU0096374516.USD","02800","LU0326950275.SGD","LU1951186391.HKD","LU0107464264.USD","LU0890818403.SGD","LU0865486749.SGD","SG9999004311.SGD","01208","IE00B031J352.USD","LU0384037296.USD","03993","LU0577902454.USD","LU0577902538.SGD","LU1880383440.USD","HTCD.SI","LU0516423091.SGD","LU0370786039.SGD","LU1282649141.HKD","LU0831103253.SGD","LU0417516738.SGD","IE0001KFT4U8.USD","LU1064131003.USD","HK0001040168.HKD","00189","LU2476274308.USD","LU0067412154.USD","LU0828237940.HKD","LU0650527681.SGD","02553","TCHmain","LU0047713382.USD","LU0648948544.HKD","LU0048597586.USD","LU0516423174.USD","LU0594300419.USD","LU1718418525.SGD","HK0000306701.USD","LU2097828714.EUR","LU0572944931.SGD","SGXZ99366536.SGD","IE0032431581.USD","LU0577902371.SGD","LU1328615791.USD","LU0329678170.USD","LU0499858602.USD","LU2097828805.USD","LU0164872284.USD","SG9999002828.SGD","LU0082770016.SGD","LU1226287792.SGD","LU0054237671.USD","LU0320764755.SGD","LU1188198961.HKD","LU1769817096.USD","LU0672654166.SGD","SG9999015945.SGD","LU0203345920.USD","LU2039709279.SGD","LU0315179316.USD","LU1046422090.SGD","LU0633140727.USD","83115","SG9999014898.SGD","LU0149534421.HKD","IE00B29SXG58.USD","LU0469268626.HKD","LU0737861699.HKD","HK0000320223.HKD","LU0164939612.USD","LU0588545730.USD","LU0417516902.SGD","LU0499858438.USD","LU2294711473.HKD","LU0823397103.USD","LU0348783233.USD","BK1606","LU0261947096.USD","SGXZ81514606.USD","LU0509642566.USD","ZIJMY","LU0737861772.HKD","LU0254981946.USD","LU2399975544.HKD","LU0784639295.USD","LU2351347302.SGD","LU1044874839.SGD","LU1048588211.SGD","688234","LU0029874905.USD","LU0163747925.USD","BK1163","LU2257852520.SGD","LU1725190679.HKD","BK1591","BK1129","LU0396098781.USD","LU1769817179.HKD","LU1734074674.USD","LU0868486357.SGD","LU1770034418.SGD","LU0819121731.USD","IE00B543WZ88.USD","LU1102505762.USD","BK1531","02099","LU0441854154.USD","IE0032834883.USD","LU0577902611.USD","00700","IE0009570106.USD","LU1675838814.USD","LU0823426480.USD","LU0228367735.SGD","LU1242518931.SGD","LU2237443978.SGD","HK0000320264.USD","BK1589","SG9999004220.SGD","BK1614","HHImain","LU0588545490.SGD","07200","SG9999017495.SGD","LU1323998911.USD","LU1196710864.SGD","LU0070217475.USD","SG9999003461.SGD","BK1191","LU1733274473.HKD","LU0620787316.HKD","LU1226288097.SGD","LU0797268264.HKD","LU0456846285.SGD","LU1794554557.SGD","LU1282649810.SGD","LU0823426308.USD","LU1988902786.USD","LU0348805143.USD","LU1956131251.USD","SGXZ90724238.SGD","LU0640798160.USD","LU0214875030.USD","LU0175139822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640136297","title":"1.8亿美元可转债“以新换旧”,绿叶制药净筹约1.77亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2640136297","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640136297?lang=zh_cn&edition=full","pubTime":"2026-06-04 10:54","pubTimestamp":1780541640,"startTime":"0","endTime":"0","summary":"6月4日,绿叶制药(02186)发布公告,公司拟对一笔1.8亿美元,利率6.25%并于2028年到期的存量可转换债券进行同步回购,合资格债券持有人每出售1000美元本金金额,可获得1031美元的回购价。同时,公司向承销商发行本金总额1.8亿美元、利率5.25%并于2031年到期的可转换债券,承销商有条件同意认购及支付债券,或促使认购人认购及支付债券。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606043760152272.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1606","BK1191","BK1583","02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640809391","title":"智通港股早知道 | 富时中国50指数调整纳入兆易创新(03986) 小马智行(02026)、文远知行(00800)纳入港股通","url":"https://stock-news.laohu8.com/highlight/detail?id=2640809391","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640809391?lang=zh_cn&edition=full","pubTime":"2026-06-04 07:36","pubTimestamp":1780529806,"startTime":"0","endTime":"0","summary":"富时中国50指数纳入兆易创新、长飞光纤光缆,删除中国铁塔、中国中车。此外,富时中国50指数还公布了新一季的备选股名单,分别为中煤能源、吉利汽车、蓝思科技、MiniMax-W、三花智控 。配售股份数目相当于于本公告日期已发行股份总数约2.01%。中国两大自动驾驶企业纳入港股通中国两大自动驾驶科技公司小马智行、文远知行WeRide宣布,正式被纳入港股通标的证券名单,该调整将于6月4日正式生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449895.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1589","WRD","BK1594","LU0314109678.HKD","LU1023057109.AUD","BK1144","600188","BK1606","BK1518","YZCAY","03986","BK1562","LU1328277881.USD","00338","BK1531","BK1538","LU0359201885.HKD","01286","LU0359202008.SGD","00354","BK1258","BK1178","BK1110","02026","BK1155","BK1229","BK1586","IE00B031HY20.USD","PONY","BK1163","00800","BK1191","BK1109","BK1583","600688","LU2039709279.SGD","BK1183","SG9999001093.SGD","02186","IE0008369823.USD","BK1526","LU0359201612.USD","BK1104","603986","LU1813983027.USD","IE0008368742.USD","01171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640867902","title":"绿叶制药(02186)拟同步回购1.8亿美元2028年到期可转换债券及发行美元计价可转换债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2640867902","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640867902?lang=zh_cn&edition=full","pubTime":"2026-06-03 20:54","pubTimestamp":1780491286,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿叶制药 发布公告,有关本公司发行1.8亿美元6.25%利率2028年到期可转换债券。本公司现拟根据该等条款及条件回购现有可转换债券。于2026年6月3日,本公司与交易经办人订立交易经办人协议,就拟进行的同步回购,交易经办人已获委任以协助本公司向可能愿意向本公司出售其现有可转换债券的现有可转换债券持有人收集意向表示。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449814.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","BK1191","02186","UDN","UUP","BNDW","BK1583"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1119705324","title":"绿叶制药2026年5月股份变动月报表:股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1119705324","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119705324?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:39","pubTimestamp":1780475986,"startTime":"0","endTime":"0","summary":"绿叶制药集团有限公司于2026年6月3日发布2026年5月股份变动月报表。报告显示,截至2026年5月31日,公司注册股本合计10,000,000,000股,每股面值为0.02美元,对应注册股本总额2亿美元。与上月相比,本月其注册股本无新增或减少。同时,公司可转换债券余额为1.8亿美元,可转换股票数量上限为288,793,032股,转股价格为每股4.88港元。本月未因可转换债券转股而新增股份。该公告由董事祝媛媛于2026年6月3日签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105225905","title":"绿叶制药授予董事股份购回授权,规模达已发行股本一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1105225905","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105225905?lang=zh_cn&edition=full","pubTime":"2026-05-29 22:07","pubTimestamp":1780063642,"startTime":"0","endTime":"0","summary":"绿叶制药集团有限公司于2026年6月1日发布公告称,将在即将召开的股东周年大会上寻求董事一般授权,可于必要时回购不超过公司已发行股份总数的10%。截至2026年5月26日,公司已发行股份合计约3,994,515,953股,若授权获准,最高回购规模可达399,451,595股。为配合大会召开,绿叶制药将于6月23日至6月26日期间暂停办理股份过户手续。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"绿叶制药授予董事股份购回授权,规模达已发行股本一成","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194264028","title":"绿叶制药4月股份变动月报表:股本规模保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1194264028","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194264028?lang=zh_cn&edition=full","pubTime":"2026-05-07 16:42","pubTimestamp":1778143326,"startTime":"0","endTime":"0","summary":"绿叶制药集团有限公司于2026年5月7日发布截至2026年4月30日止的证券变动月报表。公司在报告期内的法定股本维持10,000,000,000股,面值为每股0.02美元,总额为2亿美元。已发行普通股数量在期末为3,994,515,953股,与上月底一致,库藏股份为0股。截至本期末,绿叶制药集团无新增发行股份、无回购或注销股份,股本结构未发生变化。截至4月底,公司确认符合香港联合交易所有限公司相关公眾持股量的最低要求。以上公告由绿叶制药集团有限公司董事祝媛媛签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144597396","title":"绿叶制药2025年度收入达63.08亿元,归母净利同比增31.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1144597396","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144597396?lang=zh_cn&edition=full","pubTime":"2026-04-29 22:12","pubTimestamp":1777471967,"startTime":"0","endTime":"0","summary":"绿叶制药在报告期内实现收入人民币63.08亿元,同比上升4.1%,主要得益于部分核心产品销售扩大及授权品种贡献。年内整体盈利保持增长,母公司拥有人应占溢利为人民币6.19亿元,同比提升31.1%;集团年内溢利达到人民币7.06亿元,同比上升9.4%。经调整后,除税前溢利录得人民币9.45亿元,同比增长12.6%;EBITDA为人民币24.71亿元,同比增长12.7%。毛利总额约人民币41.63亿元,毛利率为66.0%,较上一年度略有回落但仍维持稳健水平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"绿叶制药2025年度收入达63.08亿元,归母净利同比增31.1%","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628728871","title":"绿叶制药(02186)创新药LY03015(VMAT2抑制剂╱Sigma-1R激动剂)美国PK桥接临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2628728871","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628728871?lang=zh_cn&edition=full","pubTime":"2026-04-20 20:09","pubTimestamp":1776686941,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿叶制药 发布公告,集团自主研发的新分子实体LY03015的美国药代动力学桥接临床试验已完成首例受试者入组。LY03015为全球首个囊泡单胺转运体2 抑制剂和σ-1受体激动剂,目标适应症为治疗迟发性运动障碍和亨廷顿病。LY03015通过靶向VMAT2和Sigma-1R,旨在发挥对于TD和HD两种疾病在“症状控制”和“病理改善”的双重作用。据集团所知,VMAT2抑制剂是目前唯一一类获得美国食品药品监督管理局批准上市的、用于治疗TD和HD的药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430866.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK4218","03015","BK1606","159992","06978","BK1574","BK4181","BK1191","BK1161","PK","02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627254292","title":"港股公告掘金 | 宁德时代一季度归母净利润207.38亿元 同比增长48.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627254292","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627254292?lang=zh_cn&edition=full","pubTime":"2026-04-16 09:01","pubTimestamp":1776301266,"startTime":"0","endTime":"0","summary":"【重大事项】宁德时代(03750)拟投资 300 亿元设立全资子公司 打造新能源矿产平台美格智能(03268)拟投资3亿元于AI研发及先进制造产业项目并签署投资协议力勤资源(02245):印尼镍矿政策变动不影响正常经营 与合作伙伴保持良好合作关系确保Obi项目稳定运行中远海能(01138)拟10.18亿元建造两艘巴拿马型原油轮荣昌生物(09995):收到艾伯维就RC148独家授权许可协议支付的6.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"05d74946e1a2924d42dd26ed36b9a988","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0320764755.SGD","LU0326948709.USD","BK1615","LU0505663152.USD","LU2257852520.SGD","LU1978683503.SGD","IE00BPRC5H50.USD","LU2242644610.SGD","LU0359201885.HKD","LU1880383366.USD","LU2424517915.HKD","LU0456846285.SGD","LU0797268264.HKD","LU0823397285.USD","LU1720050803.USD","LU0188438112.USD","00670","HK0000181112.HKD","LU0307460666.USD","LU0312595415.SGD","LU0052750758.USD","LU1580142542.USD","BK4526","LU0327786744.USD","02465","LU1048588211.SGD","08279","01138","LU2289578879.USD","IE00B3M56506.USD","LU2087589342.USD","LU2148510915.USD","LU0979878070.USD","LU2360107325.USD","BK1502","LU2294711473.HKD","LU0531971595.HKD","LU0417516902.SGD","00300","LU0456827905.SGD","01810","LU0611395673.USD","LU0328353924.USD","LU0651946864.USD","600026","LU0348814723.USD","LU0823414478.USD","LU2506952337.HKD","LU0143863784.USD","LU2778985437.USD","LU0251143458.SGD","BK1589","LU0651947912.USD","LU1831875114.USD","LU0828238088.HKD","LU1105468828.SGD","LU2580892862.HKD","LU0823414551.USD","LU0244354667.USD","LU0516423091.SGD","LU3063872942.SGD","LU0572944931.SGD","LU0106259558.USD","LU1008478684.HKD","BK4519","EVS.SI","LU1719994722.HKD","LU1861219969.SGD","06656","LU1868837565.USD","LU0516422952.EUR","LU1255011170.USD","LU0417516738.SGD","LU0149534421.HKD","LU2153591404.USD","LU0106959298.USD","LU0650527681.SGD","LU0463099449.HKD","LU1981816686.USD","LU0441854154.USD","LU1328277881.USD","LU0181495838.USD","LU1807302812.USD","IE00B5MMRT66.SGD","LU1997244956.HKD","LU0588546209.SGD","LU0117841782.USD","LU0214875030.USD","BK1618","LU0211977185.USD","LU1051769294.HKD","LU2097828805.USD","SG9999001903.USD","LU1039395188.USD","LU0072913022.USD","LU0449515922.USD","01898","LU1303224171.USD","300433","LU1781817850.SGD","LU2348773727.SGD","LU0823413660.USD","SGXZ81163826.USD","BK1193","LU1048596156.SGD","LU0823437842.USD","LU0455707207.USD","LU2477742899.HKD","LU1282648689.USD","LU0449509016.USD","LU1979443071.USD","LU1481107354.HKD","02556","LU0164872284.USD","LU1242518931.SGD","LU0011963245.USD","LU2294711713.HKD","LU0124384867.USD","LU2125910849.SGD","LU2275660780.HKD","BK0224","IE00B8L5B284.USD","LU0231483743.USD","SG9999003461.SGD","LU0326950275.SGD","LU0531970944.HKD","LU0823397103.USD","LU0149721374.USD","LU0543330483.HKD","IE0003851619.USD","LU0106252389.USD","HK0000165453.HKD","LU2357125470.USD","LU1152091754.HKD","LU0918141887.USD","LU2298322129.HKD","688331","03908","LU0823041008.USD","LU1251922891.USD","09995","LU0605514214.HKD","LU0871576103.HKD","LU0370786039.SGD","SGXZ49509284.SGD","LU0048580855.USD","03268","LU0516422440.USD","LU1188198961.HKD","BK4585","LU0128522157.USD","LU0823038988.USD","LU0823039010.USD","LU0880133367.SGD","LU0823426480.USD","IE00B29SXG58.USD","SG9999001689.USD","LU1993786604.SGD","03750","LU1064130708.USD","LU1997245094.SGD","LU0821914370.USD","LU0164880469.USD","LU2476274308.USD","LU1956131251.USD","IE0032431581.USD","LU0499858438.USD","LU1770036033.HKD","601111","LU1242518857.USD","LU0516423174.USD","LU1960683339.HKD","02186","LU0823426308.USD","01177","IE00B543WZ88.USD","LU0107464264.USD","LU0072462343.USD","LU0254981946.USD","LU0235996351.USD","LU1721428347.USD","LU0348805143.USD","LU2506952253.HKD","LU2153592121.USD","HXXD.SI","BK4141","LU1655091616.SGD","LU1064131003.USD","LU0594300419.USD","06613","LU2328871848.SGD","LU0210526637.USD","LU0348827113.USD","LU0405327494.USD","IE0034224299.USD","000333","LU0169518387.USD","LU1939255532.USD","LU1934453819.USD","LU0516422366.SGD","SG9999014674.SGD","00753","LU2476274720.SGD","601995","LU1868838027.USD","LU0499858602.USD","LU2226246903.HKD","LU0359201612.USD","FXCNY","LU0348816934.USD","LU1961090484.USD","LU1515016050.SGD","BK1116","IE00B8HQ1Z84.USD","LU2249611893.SGD","LU0047713382.USD","LU1146622755.USD","002881","LU0302445910.USD","LU1969619763.USD","LU0501845795.SGD","LU0828237940.HKD","LU0084288322.USD","LU2152927971.USD","LU0320764599.SGD","LU1051768304.USD","LU0348825331.USD","LU0502904849.HKD","LU0828237510.HKD","LU0132412106.USD","LU1323998911.USD","81810","LU0634319403.HKD","LU1769817096.USD","LU2125910500.SGD","SBHMY","LU0469268626.HKD","BK1610","LU0048388663.USD","LU0259732245.USD","LU2097828474.EUR","MIUmain","LU0823413587.USD","XIACY","LU0675040207.SGD","02038","02245","LU2449936058.SGD","LU1102505929.USD","LU2506952410.USD","002352","LU0228659784.USD","LU1813983027.USD","LU0724618433.USD","LU0314109678.HKD","SG9999001846.SGD","LU0029875118.USD","LU1820825898.SGD","LU0165289439.USD","LU2495084118.USD","LU0143863198.USD","BK1521","02298","LU0192582467.USD","LU1102505762.USD","LU0140636845.USD","600115","LU0918141705.HKD","LU1861214812.USD","LU0561508036.HKD","BK1523","LU2039709279.SGD","BK1575","LU2045819591.USD","SG9999000327.SGD","SG9999000459.SGD","BK1149","LU1152091168.USD","LU2399975544.HKD","LU2097828714.EUR","LU1808992512.USD","LU1770034418.SGD","LU2348774022.SGD","HK0000286598.CNH","LU0048575426.USD","LU0049853897.USD","LU2097828557.USD","SG9999002463.SGD","LU2298064838.USD","LU0708995583.HKD","IE00BD6J9T35.USD","LU0039217434.USD","LU0051755006.USD","CCOZY","LU1023057109.AUD","BK4588","06936","BK1607","01093","SG9999002828.SGD","LU1880383440.USD","LU0261950470.USD","LU0348735423.USD","LU2580892789.USD","BK1166","LU0269904917.USD","LU0405327148.USD","LU0067412154.USD","LU2097828631.EUR","HK0000181138.USD","LU0345776255.USD","LU0823040885.USD","LU0509642566.USD","LU0593848301.USD","603906","IE00BZ199S13.USD","LU0540923850.HKD","300750","LU0054450605.USD","LU0594300179.USD","LU1997245177.USD","LU0164865239.USD","SG9999001093.SGD","601898","IE0003795394.USD","LU1769817179.HKD","LU1794554557.SGD","LU0672654166.SGD","LU0359202008.SGD","BK1506","LU0607220059.USD","BK1535","LU0043850808.USD","LU0345775950.USD","LU2506951792.HKD","LU0700851271.USD","LU2238339852.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627335287","title":"绿叶制药(02186)创新药LY03017用于治疗阿尔茨海默病精神病性障碍的中国Ⅱ期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2627335287","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627335287?lang=zh_cn&edition=full","pubTime":"2026-04-15 21:03","pubTimestamp":1776258221,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿叶制药 发布公告,集团自主研发的创新药LY03017用于治疗阿尔茨海默病精神病性障碍的中国Ⅱ期临床试验已完成首例受试者入组。此次开展的中国Ⅱ期临床试验为一项随机、双盲、平行、安慰剂对照研究,旨在评估LY03017治疗阿尔茨海默病精神病性障碍相关幻觉和妄想的初步疗效和安全性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429016.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1191","02186","BK1606","BK1161","159992","06978","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627407443","title":"【券商聚焦】东北证券首予绿叶制药(02186)“增持”评级 指新产品加速放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2627407443","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627407443?lang=zh_cn&edition=full","pubTime":"2026-04-15 17:07","pubTimestamp":1776244030,"startTime":"0","endTime":"0","summary":"金吾财讯 | 东北证券发布研报指,绿叶制药 2025年业绩显示盈利能力稳健提升,新产品加速放量,在研管线陆续进入收获期,首次覆盖给予“增持”评级。2025年新产品销售额同比增长56.8%,占产品销售收入总额比例近30%。CNS领域,全球首创药物LY03015中国2期临床即将结束,美国PK桥接试验已启动;LY03017、LY03020均已在中国进入2期临床并在美国获IND批准。报告指出,公司在研管线横跨CNS、肿瘤、自免,2026年有望进入收获期。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/ZmY0OWUwYjc0ZDYzZDFkYzRkNWJlMTY3NjE5MjUxNjU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZmY0OWUwYjc0ZDYzZDFkYzRkNWJlMTY3NjE5MjUxNjU=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1979035","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186","000686"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627878492","title":"大行评级丨花旗:下调绿叶制药目标价至4.3港元,重申“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2627878492","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627878492?lang=zh_cn&edition=full","pubTime":"2026-04-14 13:47","pubTimestamp":1776145622,"startTime":"0","endTime":"0","summary":"花旗发表研报指,绿叶制药管理层指引2026年至2030年纯利复合年均增长率(CAGR)超过25%,这意味着盈利将显著改善,主要受惠于:旗下产品Erozfi在美国的销售加速增长,预计2026年销售额将翻倍至4000万美元并达到收支平衡;中国新产品持续增长。花旗基于现金流折现(DCF)估值法,将集团目标价由5港元降至4.3港元,重申“买入”评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260414/32142092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["EWH","02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627983499","title":"港股异动 | 绿叶制药(02186)午前涨近3% 近日自研创新药LY03020中国Ⅱ期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2627983499","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627983499?lang=zh_cn&edition=full","pubTime":"2026-04-14 11:54","pubTimestamp":1776138882,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,绿叶制药午前涨近3%,截至发稿,涨2.52%,报2.85港元,成交额5323.6万港元。消息面上,近日,绿叶制药发布公告,本集团自主研发的创新药LY03020的中国Ⅱ期临床已完成首例患者入组。此前,LY03020亦已在美国获准开展临床试验,是本集团在中国和海外同步开发的又一款中枢神经系统治疗领域的创新药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","06978","BK1161","02186","BK4588","159992","BK1191","VXUS","BK4585","BK1574","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627372437","title":"瑞银增持绿叶制药(02186)1395.45万股 每股作价约2.85港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627372437","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627372437?lang=zh_cn&edition=full","pubTime":"2026-04-13 19:20","pubTimestamp":1776079243,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,4月2日,瑞银增持绿叶制药(02186)1395.45万股,每股作价2.8547港元,总金额约3983.59万港元。增持后最新持股数目约4.03亿股,最新持股比例为10.09%。补充资料:218,500,000 of the reported long and short positions refer to the securities lending agreement executed in conjunction with the convertible bond issuance as disclosed on June 28 2023.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427858.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02186","BK1191","BK1606","BK1583","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625940930","title":"绿叶制药(02186):创新药LY03020中国Ⅱ期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2625940930","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625940930?lang=zh_cn&edition=full","pubTime":"2026-04-08 22:34","pubTimestamp":1775658898,"startTime":"0","endTime":"0","summary":"智通财经APP讯,绿叶制药 发布公告,本集团自主研发的创新药LY03020的中国Ⅱ期临床已完成首例患者入组。此前,LY03020亦已在美国获准开展临床试验,是本集团在中国和海外同步开发的又一款中枢神经系统治疗领域的创新药。LY03020已在早期研究中展现出积极的疗效和安全性信号。中国Ⅰ期临床研究结果表明,LY03020整体安全耐受性良好,所有治疗中出现的不良事件均为轻至中度,无EPS相关不良事件亦无严重不良事件报告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1426246.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","BK1191","BK1583","06978","02186","BK1161","159992","03020","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134731564","title":"绿叶制药2026年3月股份变动月报表,股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1134731564","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134731564?lang=zh_cn&edition=full","pubTime":"2026-04-08 21:36","pubTimestamp":1775655390,"startTime":"0","endTime":"0","summary":"绿叶制药集团有限公司于2026年4月8日公布截至2026年3月31日的股份变动月报表。报告显示,本月公司已发行股本及注册股本均未发生变化,股本结构保持稳定。公司注册股本为10,000,000,000股,面值每股USD 0.02,注册股本总额USD 200,000,000。截至3月31日,普通股已发行股份数量为3,994,515,953股,与上月底一致,本月无新增发行、购回或注销,也无库藏股变化。公司无新的股份期权及股权激励计划变动。本次公告由董事祝媛媛签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624157850","title":"BD+业绩双重炸裂,创新药多股涨停,黄金窗口期来了?","url":"https://stock-news.laohu8.com/highlight/detail?id=2624157850","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624157850?lang=zh_cn&edition=full","pubTime":"2026-04-02 14:03","pubTimestamp":1775109822,"startTime":"0","endTime":"0","summary":"进入收获期","market":"sh","thumbnail":"https://img3.gelonghui.com/a401d-e32ea773-2592-402d-a56d-8ff49dc1dd78.jpg?guru_height=718&guru_width=1280&guru_size=112216","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/a401d-e32ea773-2592-402d-a56d-8ff49dc1dd78.jpg?guru_height=718&guru_width=1280&guru_size=112216"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4283048","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["518880","BTGD","NUGT","AAAU","GCmain","MGCmain","000788","06978","GLL","SGOL","IAUM","600594","GDXD","02162","QOmain","BK4585","GLD","159992","JDST","603222","1OZmain","300086","GLTR","JNUG","OUNZ","PALL","02186","600488","SGCmain","IAU","PHYS","GDXJ","XME","159934","BK0188","CEF","GDXU","GLDM","DUST","BK1191","DZZ","IAUI","USG","UGL","000950","GDX","159831","GDXY","DGP","SGUmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188133259","title":"异动解读 | 绿叶制药盘中大涨5.17%,2025年股东应占溢利同比增长31.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188133259","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188133259?lang=zh_cn&edition=full","pubTime":"2026-04-02 10:01","pubTimestamp":1775095310,"startTime":"0","endTime":"0","summary":"绿叶制药(02186)今日盘中大涨5.17%,引起了市场的关注。消息面上,公司此前公布了2025年业绩。数据显示,2025年公司股东应占溢利同比增长31.12%,达到约6.19亿元,每股基本盈利为15.88分。公告称,公司收入同比增长4.1%至63.08亿元,收入增长主要归因于若干产品的销售及授权许可收入增加。这份强劲的业绩报告提振了投资者信心,推动了股价在交易时段内的显著上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02186"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.luye.cn","stockEarnings":[{"period":"1week","weight":0.0161},{"period":"1month","weight":-0.2286},{"period":"3month","weight":-0.2222},{"period":"6month","weight":-0.3571},{"period":"1year","weight":-0.5052},{"period":"ytd","weight":-0.3102}],"compareEarnings":[{"period":"1week","weight":-0.0098},{"period":"1month","weight":-0.0633},{"period":"3month","weight":-0.0294},{"period":"6month","weight":-0.0485},{"period":"1year","weight":0.0284},{"period":"ytd","weight":-0.0356}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"绿叶制药集团有限公司是一家主要从事药品的开发、生产、推广及销售的公司。该公司经营四个分部,包括肿瘤药物分部、心血管系统药物分部、消化与代谢药物分部和中枢神经系统药物分部。肿瘤药物分部提供力扑素、博优诺、百拓维、希美纳及米美欣等药品。心血管系统药物分部提供血脂康、欧开及麦通纳等药品。消化与代谢药物分部提供贝希等药品。中枢神经系统药物分部提供思瑞康、若欣林、瑞可妥、美比瑞及金悠平等药品。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.024212},{"month":2,"riseRate":0.333333,"avgChangeRate":0.016158},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.022436},{"month":4,"riseRate":0.5,"avgChangeRate":-0.006455},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.020854},{"month":6,"riseRate":0.333333,"avgChangeRate":0.021602},{"month":7,"riseRate":0.636364,"avgChangeRate":0.018026},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.044846},{"month":9,"riseRate":0.583333,"avgChangeRate":0.045957},{"month":10,"riseRate":0.5,"avgChangeRate":-0.00637},{"month":11,"riseRate":0.5,"avgChangeRate":0.024651},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.012685}],"exchange":"SEHK","name":"绿叶制药","nameEN":"LUYE PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"绿叶制药(02186)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供绿叶制药(02186)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"绿叶制药,02186,绿叶制药股票,绿叶制药股票老虎,绿叶制药股票老虎国际,绿叶制药行情,绿叶制药股票行情,绿叶制药股价,绿叶制药股市,绿叶制药股票价格,绿叶制药股票交易,绿叶制药股票购买,绿叶制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"绿叶制药(02186)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供绿叶制药(02186)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}